Purdue's Former President Denies Responsibility For Opioid Crisis

Purdue's Former President Denies Responsibility For Opioid Crisis

Introduction

Purdue Pharma's former president and board chair of the company claimed that he, his family, and the company are not responsible for the opioid crisis throughout the United States.

As per the court documents, every family member has denied the ill-practices of the company in terms of opioids even after being found guilty twice in opioid-related suits.

The ex-chairman has not been a part of any public forum apart from a video he gave in a 2015 lawsuit. He denied the allegations post his son's testimony in the court that states the family would not accept any settlement without guarantees of immunity in further lawsuits.

As per the Maryland Assistant Attorney General Brian Edmunds, the ex-chairman was questioned for more than three hours, and his common answer for most of the questions was that he did not recall anything.

The company was bought by the ex-chairman's father nearly 70 years ago. The former president even said that he did not recall any sales strategies that were approved by the company. He even added that he even does not recall if he had paid a part of the Oklahoma settlement on his own, where the family contributed  $75 million.

The former president did not answer any of the questions appropriately; instead, he asked more questions as informed by Edmunds.

As per a study from the U.S. Centers for Disease Control and Prevention, there have been over 500,000 deaths in the U.S. because of opioid overdose.

Earlier a settlement of up to $24.9 million was approved by the Lucas County commissioners in the statewide opioid lawsuits against the distributors and manufacturers.

Many municipalities across the state have joined the OneOhio plan that is focused on distributing funds to local jurisdictions from the National Prescription Opioid Litigation settlement, and Lucas County is one of them. The plan will ensure that each township and city within Lucas County will receive fair compensation. $809 million has been allotted to the state of Ohio from the national settlement of opioids.

AmerisourceBergen, Cardinal Health, and McKesson are the three major companies that will pay the amount of the settlement to the county. The attorney representing the county said that Lucas County is to receive between $4.5 million and $6.4 million to deal with opioid-related issues.

The amount will completely depend on the number of Ohio municipalities signing the agreement. The settlement is calculated considering the number of diagnosed opioid use disorders and deaths in the jurisdiction.

The attorney for the county even informed that a 29-member nonprofit foundation board of the county would vote to decide the best way to spend 55 percent of the settlement amount to address the opioid crisis.

The settlement would not bring the lost lives back, but it will surely help to control the further opioid crisis and deal with the currently affected users, said the attorney for the county. The board president of the nonprofit foundation said that the amount is huge, but splitting the settlement for 18 years is the best way to compensate the affected users, counties, and municipalities.

The attorney even informed that Johnson & Johnson (J&J) is also a part of the national opioid litigation, but it is not liable for this portion of the settlement.

Earlier, Connecticut's attorney general has committed to getting $300 million for the state from the $26 billion opioid settlement offered by the pharmaceutical distributors and drugmaker Johnson & Johnson (J&J).

Attorney General William Tong wrote in a letter informing about how the settlement amount will fund strategies, initiatives and programs. It will help the states, victims and their families to overcome the opioid crisis.

Some advocates and politicians have objected to depositing the settlement amount in the state’s general fund. They showed concern considering the misuse of the millions of dollars received by the state every year in the 1998 Big Tobacco settlement for smoking prevention and cessation.

Connecticut will receive $300 million over the next 18 years, as per the agreement. The state will get $26 million for the initial three years, and a varied sum of amount will be allotted for the next fifteen years. Pharmaceutical distributors McKesson Corp., Cardinal Health and AmerisourceBergen, along with J&J, will pay the amount.

Municipalities and the state signing on the agreement will get 85% and 15% respectively from the settlement amount allotted to Connecticut. 70% of the allotted funds to the state will be used for controlling future crisis whereas 15% will be used for general abatement measures. The amount will also cover the attorney's fees.

Last year, opioid overdose claimed 1,400 lives in Connecticut and 93,000 lives throughout the nation.

J&J even face several lawsuits over its talcum powder products, with nationwide women alleging the company's baby powder of causing ovarian cancer. 12,00 women and their families have filed lawsuits against the company in the past 25 years with similar allegations of cancer-causing ingredients in the talc products.